Avricore Health (AVCRF) EBIT Margin (2015 - 2025)
Avricore Health (AVCRF) reported EBIT Margin of 1012.72% for Q3 2025, down 99808.0% year-over-year from N/an in Q3 2024, and up 38.7% quarter-over-quarter from 1651.97% in Q2 2025.
Avricore Health (AVCRF) EBIT Margin (2015 - 2025) Analysis & Trends
Avricore Health (AVCRF) has 11 years of EBIT Margin data on file, last reported at 1012.72% in Q3 2025.
- EBIT Margin for Q3 2025 came in at 1012.72%, down 99808.0% year-over-year; the trailing twelve-month figure through Sep 2025 was 65.26% (down 6755.0% YoY), and the FY2025 annual result was 259.13%, down 26183.0% from the prior year.
- EBIT Margin improved to 1012.72% in Q3 2025 per AVCRF's latest filing, from 1651.97% in the prior quarter.
- Over five years, EBIT Margin peaked at 20.38% in Q1 2023 and troughed at 1651.97% in Q2 2025.
- A 5-year average of 281.69% and a median of 30.96% in 2022 frame the typical range for EBIT Margin.
- The sharpest annual moves came in 2022 and 2025: EBIT Margin surged 121135 bps in 2022, then tumbled 165714 bps in 2025.
- A 5-year view of EBIT Margin shows it stood at 115.12% in 2021, then jumped by 79 bps to 24.43% in 2022, then soared by 121 bps to 5.07% in 2023, then sank by 389 bps to 14.64% in 2024, then tumbled by 6816 bps to 1012.72% in 2025.
- Business Quant data shows AVCRF's EBIT Margin at 1012.72% in Q3 2025, 1651.97% in Q2 2025, and 17.48% in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | -3.71% |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 16.93% |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 22.58% |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 31.78% |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 21.74% |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | -13.42% |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | 12.38% |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 19.16% |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | 25.23% |
| 10 | Avricore Health | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -1,012.72% |
| Jun 30, 2025 | -1,651.97% |
| Mar 31, 2025 | -17.48% |
| Sep 30, 2024 | -14.64% |
| Jun 30, 2024 | 5.17% |
| Mar 31, 2024 | 14.10% |
| Dec 31, 2023 | 5.07% |
| Sep 30, 2023 | -29.84% |
| Jun 30, 2023 | -51.85% |
| Mar 31, 2023 | 20.38% |
| Dec 31, 2022 | -24.43% |
| Sep 30, 2022 | -32.07% |
| Jun 30, 2022 | -119.12% |
| Mar 31, 2022 | -57.87% |
| Dec 31, 2021 | -115.12% |
| Sep 30, 2021 | -23.27% |
| Jun 30, 2021 | -1,330.47% |
| Mar 31, 2021 | -634.28% |
| Dec 31, 2020 | -364.32% |
| Sep 30, 2020 | -189.16% |